China Biologic Products (CBPO) Tops Q4 EPS by 1c

China Biologic Products (NASDAQ: CBPO) reported Q4 EPS of $0.90, $0.01 better than the analyst estimate of $0.89. Revenue for the quarter came in at $90.1 million versus the consensus estimate of $85.15 million.

For earnings history and earnings-related data on China Biologic Products (CBPO) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BWS Financial Downgrades Inter Parfums (IPAR) to Sell